Drug treatment of epilepsy
- 1 June 1994
- journal article
- review article
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 32 (6) , 45-48
- https://doi.org/10.1136/dtb.1994.32645
Abstract
Epilepsy is a common neurological disorder. As many as 1 in 20 of the general population have a fit1 at some time in their lives, and at any one time around 200 000 people in the UK are taking antiepileptic drugs.2 On treatment at least two-thirds of patients are likely to be free of attacks1 and eventually almost two-thirds are likely to be fit-free on no medication.3 In this article we review the drugs used to control epilepsy and consider how and when they can be withdrawn.Keywords
This publication has 16 references indexed in Scilit:
- Clinical use of lamotrigineSeizure, 1992
- Helicobacter pylori-associated gastritis and primary B-cell gastric lymphomaThe Lancet, 1991
- Antiepileptic drug withdrawal— hawks or doves?The Lancet, 1991
- Established anticonvulsants and treatment of refractory epilepsyThe Lancet, 1990
- Diagnosis of epilepsyThe Lancet, 1990
- Epidemiology, classification, natural history, and genetics of epilepsyThe Lancet, 1990
- Phenobarbital for Febrile Seizures — Effects on Intelligence and on Seizure RecurrenceNew England Journal of Medicine, 1990
- Discontinuing Antiepileptic Medication in Children with Epilepsy after Two Years without SeizuresNew England Journal of Medicine, 1985
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985
- Hyponatremia during carbamazepine therapyClinical Pharmacology & Therapeutics, 1985